References
- Burt V L, Whelton P, Roccella E J, Brown C, Cutler J A, Higgins M, Horan M J, Labarthe D. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension 1995; 25: 305–313, [PUBMED], [INFOTRIEVE], [CSA]
- Ueshima H, Zhang X H, Choudhury S R. Epidemiology of hypertension in China and Japan. J Hum Hypertens 2000; 14: 765–769, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Materson B J, Reda D J, Cushman W C, Massie B M, Freis E D, Kochar M S, Hamburger R J, Fye C, Lakshman R, Ramirez E A, Henderson W G. Single‐drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 1993; 328: 914–921, [CROSSREF]
- Weinshilboum R. Inheritance and drug response. N Engl J Med 2003; 348: 529–537, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Evans W E, McLeod H L. Pharmacogenomics–drug disposition, drug targets, and side effects. N Engl J Med 2003; 348: 538–549, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Moser M, Abraham P A, Bennett W M, Brachfeld N, Goodman R P, McKenney J M, Hollifield J W, Kirkendall W M, Lasseter K C, Leon A S, et al. The effects of benazepril, a new angiotensin‐converting enzyme inhibitor, in mild to moderate essential hypertension: a multicenter study. Clin Pharmacol Ther 1991; 49: 322–329, [PUBMED], [INFOTRIEVE]
- Whalen J J. Definition of the effective dose of the converting‐enzyme inhibitor benazepril. Am Heart J 1989; 117: 728–734, [PUBMED], [INFOTRIEVE]
- Balfour J A, Goa K L. Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure. Drugs 1991; 42: 511–539, [PUBMED], [INFOTRIEVE]
- Kobilka B K, Dixon R A, Frielle T, Dohlman H G, Bolanowski M A, Sigal I S, Yang‐Feng T L, Francke U, Caron M G, Lefkowitz R J. cDNA for the human beta 2‐adrenergic receptor: a protein with multiple membrane‐spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet‐derived growth factor. Proc Natl Acad Sci U S A 1987; 84: 46–50, [PUBMED], [INFOTRIEVE], [CSA]
- Kazanietz M G, Enero M A. Desensitization of the beta‐2 adrenoceptor‐mediated vasodilation in rat aorta after prolonged treatment with the beta‐2 adrenoceptor agonist clenbuterol. J Pharmacol Exp Ther 1990; 252: 758–764, [PUBMED], [INFOTRIEVE], [CSA]
- Ramsdale E H, Otis J, Kline P A, Gontovnick L S, Hargreave F E, O'Byrne P M. Prolonged protection against methacholine‐induced bronchoconstriction by the inhaled beta 2‐agonist formoterol. Am Rev Respir Dis 1991; 143: 998–1001, [PUBMED], [INFOTRIEVE]
- Portillo M P, Del Barrio A S, Garcia‐Calonge M A, Martinez J A. Desensitization effect of in vivo treatment with metaproterenol on beta1, beta2 and beta3‐adrenergic responsiveness in rat adipocytes. Life Sci 1996; 58: 405–414, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Reihsaus E, Innis M, MacIntyre N, Liggett S B. Mutations in the gene encoding for the beta 2‐adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993; 8: 334–339, [PUBMED], [INFOTRIEVE]
- Green S A, Turki J, Innis M, Liggett S B. Amino‐terminal polymorphisms of the human beta 2‐adrenergic receptor impart distinct agonist‐promoted regulatory properties. Biochemistry 1994; 33: 9414–9419, [PUBMED], [INFOTRIEVE]
- Green S A, Turki J, Bejarano P, Hall I P, Liggett S B. Influence of beta 2‐adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol 1995; 13: 25–33, [PUBMED], [INFOTRIEVE], [CSA]
- Gratze G, Fortin J, Labugger R, Binder A, Kotanko P, Timmermann B, Luft F C, Hoehe M R, Skrabal F. Beta‐2 Adrenergic receptor variants affect resting blood pressure and agonist‐induced vasodilation in young adult Caucasians. Hypertension 1999; 33: 1425–1430, [PUBMED], [INFOTRIEVE], [CSA]
- Bray M S, Krushkal J, Li L, Ferrell R, Kardia S, Sing C F, Turner S T, Boerwinkle E. Positional genomic analysis identifies the beta(2)‐adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation 2000; 101: 2877–2882, [PUBMED], [INFOTRIEVE]
- Kotanko P, Binder A, Tasker J, DeFreitas P, Kamdar S, Clark A J, Skrabal F, Caulfield M. Essential hypertension in African Caribbeans associates with a variant of the beta2‐adrenoceptor. Hypertension 1997; 30: 773–776, [PUBMED], [INFOTRIEVE], [CSA]
- Candy G, Samani N, Norton G, Woodiwiss A, Radevski I, Wheatley A, Cockcroft J, Hall I P. Association analysis of beta2 adrenoceptor polymorphisms with hypertension in a Black African population. J Hypertens 2000; 18: 167–172, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kato N, Sugiyama T, Morita H, Kurihara H, Sato T, Yamori Y, Yazaki Y. Association analysis of beta(2)‐adrenergic receptor polymorphisms with hypertension in Japanese. Hypertension 2001; 37: 286–292, [PUBMED], [INFOTRIEVE]
- Laird N M, Horvath S, Xu X. Implementing a unified approach to family‐based tests of association. Genet Epidemiol 2000; 19(suppl 1)S36–S42, [PUBMED], [INFOTRIEVE]
- Li D, Xing H, Hao K, Peng S, Wu D, Guang W, Huang A, Wang Y, Zhang Y, Yu Y, Li J, Chen C, Wang B, Zhu G, Huo Y, Chen D, Ronnenberg A, Niu T, Xu X. Hypertensive patients from two rural Chinese counties respond differently to benazepril: the anhui hypertension health care study. Ann Epidemiol 2004; 14: 123–128, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- MacNab M, Mallows S. Safety profile of benazepril in essential hypertension. Clin Cardiol 1991; 14: IV33–IV37, discussion IV51–5[PUBMED], [INFOTRIEVE]
- Postma C T, Dennesen P J, de Boo T, Thien T. First dose hypotension after captopril; can it be predicted? A study of 240 patients. J Hum Hypertens 1992; 6: 205–209, [PUBMED], [INFOTRIEVE]
- Palatini P, Mos L, Motolese M, Mormino P, Del Torre M, Varotto L, Pavan E, Pessina A C. Effect of evening versus morning benazepril on 24‐hour blood pressure: a comparative study with continuous intraarterial monitoring. Int J Clin Pharmacol Ther Toxicol 1993; 31: 295–300, [PUBMED], [INFOTRIEVE]
- Niu T, Chen C, Yang J, Wang B, Wang Z, Schork N, Fang Z, Xu X. Blood pressure and the T174M and M235 T polymorphisms of the angiotensinogen gene. Ann. Epidemiol. 1999; 9: 245–253, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Buffone G J, Darlington G J. Isolation of DNA from biological specimens without extraction with phenol. Clin Chem 1985; 31: 164–165, [PUBMED], [INFOTRIEVE]
- Niu T, Struk B, Lindpaintner K. Statistical considerations for genome‐wide scans: design and application of a novel software package polymorphism. Hum Hered 2001; 52: 102–109, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Rabinowitz D, Laird N. A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. Hum Hered 2000; 50: 211–223, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ranade K, Shue W H, Hung Y J, Hsuing C A, Chiang F T, Pesich R, Hebert J, Olivier M, Chen Y D, Pratt R, Olshen R, Curb D, Botstein D, Risch N, Cox D R. The glycine allele of a glycine/arginine polymorphism in the beta2‐adrenergic receptor gene is associated with essential hypertension in a population of Chinese origin. Am J Hypertens 2001; 14: 1196–1200, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Taylor D R, Kennedy M A. Beta‐adrenergic receptor polymorphisms and drug responses in asthma. Pharmacogenomics 2002; 3: 173–184, [PUBMED], [INFOTRIEVE], [CSA]
- O'Connor D T, Insel P A, Ziegler M G, Hook V Y, Smith D W, Hamilton B A, Taylor P W, Parmer R J. Heredity and the autonomic nervous system in human hypertension. Curr Hypertens Rep 2000; 2: 16–22, [PUBMED], [INFOTRIEVE], [CSA]
- Goldstein D S. Plasma catecholamines and essential hypertension. An analytical review. Hypertension 1983; 5: 86–99, [PUBMED], [INFOTRIEVE]
- Dage R C, Hsieh C P, Spedding M. Vasodilation by medroxalol mediated by beta 2‐adrenergic receptor stimulation. J Cardiovasc Pharmacol 1983; 5: 143–150, [PUBMED], [INFOTRIEVE], [CSA]
- Chitbangonsyn S W, Mahboubi P, Walker D, Rana B K, Diggle K L, Timberlake D S, Parmer R J, O'Connor D T. Physical mapping of autonomic/sympathetic candidate genetic loci for hypertension in the human genome: a somatic cell radiation hybrid library approach. J Hum Hypertens 2003; 17: 319–324, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Jablonskis L T, Rogers P F, Lungershausen Y K, Howe P R. Chronic central administration of enalaprilat lowers blood pressure in stroke‐prone spontaneously hypertensive rats. J Auton Nerv Syst 1992; 39: 119–126, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sloman G. Angiotensin‐converting enzyme inhibition, the sympathetic nervous system, and congestive heart failure. The Australian Zestril (Lisinopril) Study Group. Am J Cardiol 1992; 70: 113C–118C, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Giannattasio C, Cattaneo B M, Omboni S, Seravalle G, Bolla G, Turolo L, Morganti A, Grassi G, Zanchetti A, Mancia G. Sympathomoderating influence of benazepril in essential hypertension. J Hypertens 1992; 10: 373–378, [PUBMED], [INFOTRIEVE]
- Spielman R S, McGinnis R E, Ewens W J. Transmission test for linkage disequilibrium: the insulin gene region and insulin‐dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506–516, [PUBMED], [INFOTRIEVE], [CSA]
- Wang Z, Chen C, Niu T, Wu D, Yang J, Wang B, Fang Z, Yandava C N, Drazen J M, Weiss S T, Xu X. Association of asthma with beta(2)‐adrenergic receptor gene polymorphism and cigarette smoking. Am J Respir Crit Care Med 2001; 163: 1404–1409, [CSA]